| Financial Year |
March 31 2023 |
| Monetary Funds |
116,956,138.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
156,131,486.66 |
| Advances to Suppliers |
35,000,000.00 |
| Other Receivables |
1,151,326.96 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,118,255,805.95 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,364,033.03 |
| Total Current Assets |
2,456,858,790.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
248,477,400.62 |
| Fixed Assetes |
516,866.62 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
117,535.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
52,672.27 |
| Deferred Income Tax Assets |
46,337,946.56 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
345,786,132.77 |
| Total Assets |
2,802,644,923.63 |
| Short-Term Loans |
514,051,059.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
145,648,039.38 |
| Accounts Received In Advance |
5,327,165.66 |
| Employee Compensation Payable |
1,735,285.58 |
| Taxes Payable |
167,905,817.26 |
| Interest Payable |
804,755.70 |
| Dividend Payable |
8,805,159.22 |
| Other payables |
36,807,901.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
51,619,238.95 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
925,458,317.27 |
| Long-term Loans |
68,470,798.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
46,302,829.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
122,171,628.38 |
| Total Liabilities |
1,047,629,945.65 |
| Paid-In Capital(Or Share Stock) |
646,115,826.00 |
| Capital Surplus |
412,590,525.25 |
| Surplus Reserve |
110,202,805.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
586,105,821.33 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,755,014,977.98 |
| Owner's Equity（Stockholder's Equity） |
1,755,014,977.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,802,644,923.63 |
